נפח מכירות החברה scinai.com (SCNI)

Current sales demonstrate the growth dynamics of Scinai Immunotherapeutics (SCNI), where 0.00 indicates the level of this metric. Growth is driven by a revision of the R&D strategy toward nanobodies for dermatology. Revenue is based on the creation of biologics for infections and contract services. Business efficiency is increasing through the implementation of robotic filling lines, which eliminate personnel errors during antibody production.
פילוחי מדדים מקיפים ואנליטיקה עבור BiondVax Pharmaceuticals (SCNI)

Scinai Immunotherapeutics' high authority in the field of nanobodies allows for the assessment of the commercial potential of their developments through actual cash inflows from sales. The current value of 0.00, reflected in the company's sales history, measures real sales volume, excluding speculative expectations and confirming the fundamental stability of the business, which is critical for minimizing risks during a market reversal.